Company intelligence
Bristol Myers Squibb
About Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html
Verified activity
Signals from Bristol Myers Squibb
51 published signals
Presence & Recognition
Bristol Myers Squibb France team will depart for the 11th edition of Country 2 Country 4 Cancer from 16 to 18 September.
Reported by Bristol Myers Squibb
Research & Knowledge
Bristol Myers Squibb announced positive topline results from a registrational Phase 2 trial evaluating an investigational CAR T cell therapy in certain patients with relapsed or refractory multiple myeloma.
Reported by Bristol Myers Squibb
People
Bristol Myers Squibb General Manager Spain & Portugal Sandra Orta accepted her new role in BMS in the United States.
Reported by Sandra Orta
Research & Knowledge
Bristol Myers Squibb published a pharmacometrics methodology paper on the practical implementation of stochastic differential equations in NONMEM online in The AAPS Journal
Reported by YAN LI
Customers & Market
Bristol Myers Squibb announced that Owkin’s K Pro AI Scientist, licensed by AstraZeneca in May, Sanofi in June, and Boehringer on September 2, is emerging as a shared R&D intelligence layer.
Reported by Sujit Ghosh
People
Bristol Myers Squibb connected with Thorough Group to connect with hiring exceptional talent or looking for a biotech opportunity.
Reported by Jeena M. Thevathasan
Research & Knowledge
Bristol Myers Squibb researchers used AI to map over 1,800 protein interactions linked to autism risk genes and found that mutations converged on a small set of shared pathways.
Reported by Carrie Williams, PMP
Presence & Recognition
Bristol Myers Squibb employee Amelie Jung participated in the Country to Country for Cancer team.
Reported by Amelie Jung
People
Bristol Myers Squibb is hiring an Associate Director, Computational Sciences — Biotherapeutics Portfolio Group Lead to lead project teams in antibody discovery, molecule design, optimization, and program advancement across oncology, neuroscience, and immunology.
Reported by Brian Kidd
Research & Knowledge
Bristol Myers Squibb is investigating the role of the lysophosphatidic acid receptor 1 (LPA1) pathway to better understand the biological processes contributing to pulmonary fibrosis.
Reported by Bristol Myers Squibb
Presence & Recognition
Bristol Myers Squibb colleagues from Germany and the Czech Republic started the 2026 edition of Country 2 Country 4 Cancer (C2C4C) Europe in Munich.
Reported by Emma Charles
Research & Knowledge
Bristol Myers Squibb published the 2026 W36 TidyTuesday report and the Cappuccino Index.
Reported by Steven Ponce
Presence & Recognition
Bristol Myers Squibb participated in the MakeoverMonday 2026 W36 event featuring the Bears Will Be Boys.
Reported by Steven Ponce
Presence & Recognition
Bristol Myers Squibb announced that ticket sales will close for the first-ever Ireland Sterile Community of Practice Face-to-Face Event with registration closing on 11 September.
Reported by Maria Ginnelly
Presence & Recognition
Bristol Myers Squibb received the 2026 Fierce AI Innovation Award for their hard work, creativity, and collaboration.
Reported by Adam Lenkowsky
Presence & Recognition
Bristol Myers Squibb employee Amine AZIEZ spoke at CACA & CTOP 2026 in Shanghai, reconnecting with Prof. Zhou.
Reported by Amine AZIEZ
Presence & Recognition
Bristol Myers Squibb Canada is highlighting three types of cancer in September: leukemia, lymphoma, and myeloma.
Reported by Bristol Myers Squibb
Research & Knowledge
Bristol Myers Squibb researchers are advancing the science of pulmonary fibrosis, investigating potential new approaches for people living with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.
Reported by Bristol Myers Squibb
Presence & Recognition
Bristol Myers Squibb employee Rick Hall is presenting a talk on meeting current demands and potential Coginiti.
Reported by Andrew Wynn
Presence & Recognition
Bristol Myers Squibb named Patricia Russo a PM360 2026 Trailblazer Brand Champion in the Global Marketing category for CNS, bringing therapy for treating schizophrenia onto BMS's GenAI-enabled content platform.
Reported by Patricia Russo
Presence & Recognition
Bristol Myers Squibb is hosting a panel discussion at AAPS PharmSci 360 2026 on October 26, 2026, featuring Dr. Parag Kolhe, Dr. Alfred Rumondor, and Dr. Ryan Soderquist from Pfizer, AbbVie, and Merck respectively.
Reported by Swita R. Singh, Ph.D.
People
Bristol Myers Squibb is hiring for a payroll specialist role requiring challenges, innovation, AI use, and learning new things.
Reported by Karen Buckley
People
Bristol Myers Squibb successfully completed the MIT CTL Supply Chain Education Program for its supply chain professionals through the Massachusetts Institute of Technology.
Reported by Rafael Viaro, MBA, CSCP
Presence & Recognition
Bristol Myers Squibb announced that the HBA Lisbon activity is starting and the pannel of speakers will be shared.
Reported by Susana Maria